SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HYBN: Hybridon, Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JMarcus who wrote (20)3/19/2004 12:17:17 PM
From: Gulo  Read Replies (2) of 28
 
To bring the thread up to date:

Jan 30/04
Hybridon's AEG35156/GEM®640, under development by Aegera THeraputics, "Exhibits Significant Antitumor Activity "
hybridon.com

Feb 24/04
Aegera raises $20M from Canada's top biotech venture capital groups to fund development of AEG35156/GEM®640:
aegera.com

HBY insiders continue to accumulate shares, including open market purchases:
cbs.marketwatch.com

I know the stock isn't attracting much attention, but it might within a couple months.
-g
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext